Skip to main content
. Author manuscript; available in PMC: 2016 May 24.
Published in final edited form as: J Psychoactive Drugs. 2012 Apr-Jun;44(2):166–172. doi: 10.1080/02791072.2012.684633

Table 1. Treatment Responders versus Non-responders (N=64).

Characteristic Responders
(N = 17)
Non-Responders
(N = 47)
Total
(N = 64)
N (%) or
Mean (SD)
N (%) or
Mean (SD)
N (%) or
Mean (SD)
Race/Ethnicity
 Caucasian/white 13 (76.5%)* 22 (46.8%)* 35 (54.7%)
 African American/black 3 (17.7%) 11 (23.4%) 14 (21.9%)
 Hispanic/Latino 1 (5.9%) 10 (21.3%) 11 (17.2%)
 Other/Multiracial 0 (0%) 4 (8.5%) 4 (6.3%)
Lifetime Cocaine Use
 Years 2.5 (3.6)* 5.9 (7.7)* 5 (7)
Lifetime Methamphetamine Use
 Years 3.8 (4.2)* 6.7 (6.7)* 5.9 (6.1)
Lifetime Polysubstance Use
 Years 7.8 (4.4)* 12.9 (8.5)* 11.6 (7.9)
# Male Sexual Partners
 Last 6 Months 11.8 (16.7) 5.5 (8.5) 7.2 (11.4)
# Unprotected Anal Intercourse
 Last 6 Months 24.9 (61.4)* 2.5 (9.9)* 8.5 (33.6)

p ≤ .1;

*

p ≤ .05

All sig. tests 2-tailed.